Effects of synthetic cannabinoids on electroencephalogram power spectra in rats

Forensic Science International

Volumn 215, Issue 1-3, 2012, Pages 179-183

  Uchiyama, Nahoko ^a   Kikura Hanajiri, Ruri ^a   Matsumoto, Naomi ^b   Huang, Zhi Li ^b   Goda, Yukihiro ^a   Urade, Yoshihiro ^b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Cannabicyclohexanol; CP 47,497; Electroencephalogram; JWH 018; Locomotor activity; Synthetic cannabinoids

Indexed keywords

1 NAPHTHALENYL(1 PENTYL 1H INDOL 3 YL)METHANONE; 3 [2 HYDROXY 4 (2 METHYLOCTAN 2 YL)PHENYL]CYCLOHEXAN 1 OL; CANNABICYCLOHEXANOL; CANNABINOID; DRONABINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; LOCOMOTION; MALE; NONHUMAN; POWER SPECTRUM; PRIORITY JOURNAL; RAT;

EID: 84856495935     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.05.005     Document Type: Article

References (32)

1. Uchiyama N., Kikura-Hanajiri R., Kawahara N., Haishima Y., Goda Y. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 2009, 57:439-441.
2. Auwärter V., Dresen S., Weinmann W., Müller M., Pütz M., Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J. Mass Spectrom. 2009, 44:832-837.
3. Uchiyama N., Kikura-Hanajiri R., Kawahara N., Goda Y. Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 2009, 27:61-66.
4. Zweiundzwanzigste Verordnung, zur Änderung betäubungsmittelrechtlicher Vorschriften (2009), Germany. BGBl I Nr. 3 vom 21.01.2009, 22. BtMÄndV vom 19. January 2009, S. 49-50. (accessed January 2009). http://www.bgblportal.de/BGBL/bgbl1f/bgbl109s0049.pdf.
5. EMCDDA Action on New Drugs Briefing Paper: Understanding the 'Spice' Phenomenon (a Report from an EMCDDA Expert Meeting, 6 March 2009, Lisbon). (accessed April 2010). http://www.emcdda.europa.eu/attachements.cfm/att_80086_EN_Spice%20Thematic%20paper%20-%20final%20version.pdf.
6. Lindigkeit R., Boehme A., Eiserloh I., Luebbecke M., Wiggermann M., Ernst L., Beuerle T. Spice: A never ending story?. Forensic Sci. Int. 2009, 191:58-63.
7. Uchiyama N., Kikura-Hanajiri R., Ogata J., Goda Y. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci. Int. 2010, 198:31-38.
8. Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015 JWH-200 and JWH-073 as designer drugs in illegal products. Forensic Toxicol. 2011, 29:25-37.
9. Weissman A., Milne G.M., Melvin L.S. Cannabimimetic activity from CP-47 497, a derivative of 3-phenylcyclohexanol. J. Pharmacol. Exp. Ther. 1982, 223:516-523.
10. Melvin L.S., Johnson M.R., Herbert C.A., Milne G.M., Weissman A. A cannabinoid derived prototypical analgesic. J. Med. Chem. 1984, 27:67-71.
11. Howlett A.C., Johnson M.R., Melvin L.S., Milne G.M. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol. Pharmacol. 1988, 33:297-302.
12. Compton D.R., Johnson M.R., Melvin L.S., Martin B.R. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 1992, 260:201-209.
13. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 1993, 265:218-226.
14. Wiley J.L., Compton D.R., Dai D., Lainton J.A., Phillips M., Huffman J.W., Martin B.R. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 1998, 285:995-1004.
15. Aung M.M., Griffin G., Huffman J.W., Wu M., Keel C., Yang B., Showalter V.M., Abood M.E., Martin B.R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 2000, 60:133-140.
16. Huffman J.W. Cannabimimetic indoles, pyrroles and indenes: structure-activity relationships and receptor interactions. The Cannabinoid Receptors 2009, 49-94. Humana Press, New York. P.H. Reggio (Ed.).
17. Huffman J.W., Padgett L.W. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr. Med. Chem. 2005, 121:1395-1411.
18. Pacher P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006, 58:389-462.
19. Krijzer F., Herrmann W.M. Advances in Pharmaco-EEG 1996, International Pharmaco-EEG Group.
20. Robbe D., Montgomery S.M., Thome A., Rueda-Orozco P.E., McNaughton B.L., Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat. Neurosci. 2006, 9:1526-1533.
21. Ilan A.B., Smith M.E., Gevins A. Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl.) 2004, 176:214-222.
22. Melvin L.S., Johnson M.R., Herbert C.A., Milne G.M., Weissman A.A. A cannabinoid derived prototypical analgesic. J. Med. Chem. 1984, 27:67-71.
23. Hong Z.Y., Huang Z.L., Qu W.M., Eguchi N., Urade Y., Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 2005, 92:1542-1549.
24. Huang Z.L., Mochizuki T., Qu W.M., Hong Z.Y., Watanabe T., Urade Y., Hayaishi O. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4687-4692.
25. Oishi Y., Huang Z.L., Fredholm B.B., Urade Y., Hayaishi O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19992-19997.
26. Kohtoh S., Taguchi Y., Matsumoto N., Wada M., Huang Z.L., Urade Y. Algorithm for sleep scoring in experimental animals based on fast Fourier transform power spectrum analysis of the electroencephalogram. Sleep Biol. Rhythms 2008, 6:163-171.
27. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
28. Teske J., Weller J.P., Fieguth A., Rothämel T., Schulz Y., Tröger H.D. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878:2659-2663.
29. Sobolevsky T., Prasolov I., Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200:141-147.
30. Thomas B.F., Martin B.R. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1 1-dimethylheptyl) phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog. Drug Metab. Dispos. 1990, 18:1046-1054.
31. Harvey D.J., Paton W.D.M. Metabolism of the cannabinoids. Rev. Biochem. Toxicol. 1984, 221-264. Elsevier, New York. E. Hodgson, J.R. Bend, R.M. Philpot (Eds.).
32. Atwood B.K., Huffman J., Straiker A., Mackie K. JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist. Br. J. Pharmacol. 2010, 160:585-593.